Fierce Pharma
JANUARY 24, 2023
Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 - 16:13
MedCity News
JANUARY 24, 2023
Amazon’s RxPass offers more than 50 generic drugs for more than 80 common conditions at the flat fee of $5 a month for Prime members. While one expert says its a significant move by Amazon, another said more needs to be done.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 24, 2023
Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody ntaylor Tue, 01/24/2023 - 05:45
MedCity News
JANUARY 24, 2023
Wisdo, a social health platform that addresses loneliness and social isolation, teamed up with Humana to serve some of its Medicare Advantage members. A new study on Humana’s members found that 58% of participants reported lower rates of loneliness after three months of using Wisdo’s app.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
JANUARY 24, 2023
Bayer’s oncology business looks to collect $10B in sales by 2030, exec says zbecker Tue, 01/24/2023 - 09:14
MedCity News
JANUARY 24, 2023
Digital health’s investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. 1. Competing for attention: Bandwidth stress Healthcare systems will continue to be hugely stretched in 2023, and that limits the engagement that pharmaceutical companies have with healthcare professionals to promote the
Fierce Pharma
JANUARY 24, 2023
Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work ntaylor Tue, 01/24/2023 - 05:42
MedCity News
JANUARY 24, 2023
Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.
Fierce Pharma
JANUARY 24, 2023
J&J's Duato keeps $60B sales target in sight even as Imbruvica slides and Stelara nears patent cliff fkansteiner Tue, 01/24/2023 - 11:19
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedReps
JANUARY 24, 2023
Everyone knows the old adage – it’s not what you know, it’s who you know. This rings true in most industries, but especially in more competitive fields like medical sales. The statistics say it all. According to research by Team Stage , 75% of all people surveyed, whether they’re seeking a job or not, spend some time networking. 72% of all networkers make snap judgements on those they’re meeting based on their professional demeanor, and 85% of all positions are filled with empl
Fierce Pharma
JANUARY 24, 2023
Novartis, in SCOTUS filing, argues it was 'wrongly deprived' of Gilenya patent after judge's retirement zbecker Tue, 01/24/2023 - 11:21
MedCity News
JANUARY 24, 2023
By following a checklist of considerations to ensure vendors are up to par with regulations and industry standards, you will be protected against any potential future liabilities and ensure that your Personal Health Information is protected.
Fierce Pharma
JANUARY 24, 2023
How a buyer's sudden withdrawal gave Ipsen a chance to fight for Albireo aliu Tue, 01/24/2023 - 10:29
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
European Pharmaceutical Review
JANUARY 24, 2023
Velocity Clinical Research , the largest integrated research site organisation globally, has made three all-female key leadership hires. This move strengthens its European senior executive team as the firm continues its expansion in the region. The three new European hires are: Maria Lehretz, Medical Director, Velocity Leipzig, Germany Maria has nearly a decade of experience as a clinical research physician, and has worked on approximately 70 clinical trials.
Fierce Pharma
JANUARY 24, 2023
Investors kibosh Midatech merger, triggering scramble for cash ntaylor Tue, 01/24/2023 - 09:52
InCrowd
JANUARY 24, 2023
In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels. In November of that year, InCrowd surveyed US physicians to understand how physicians are managing work-related stress and burnout, to explore physician feelings on their profession, and better understand how medical facilities can address physician burnout.
pharmaphorum
JANUARY 24, 2023
Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. Recent years have brought a revolution to the way in which patients receive treatment.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharma Pathway
JANUARY 24, 2023
Shilpa Medicare Ltd –Walk-In Interviews for Quality Control On 25th to 28th Jan’ 2023 Job Description Walk-In Interviews for Quality Control On 25th to 28th Jan’ 2023 @ Shilpa Medicare Ltd Department: Quality Control-Formulation Designation: Executive/ Senior Executive Qualification: B.Pharm/ M.Pharm/ M.Sc Experience: 01 to 05 years Job Location: Nacharam, Hyderabad Date : 25th to 28th Jan’ 2023 Time: 09:00 AM to 12:00 PM Venue: Plot No. 79, Survey No 125, IDA Mallapur, Up
pharmaphorum
JANUARY 24, 2023
Eli Lilly is leaving nothing to chance when it comes to making the most of its fast-growing diabetes therapy Mounjaro – it is investing another $450 million at a facility in North Carolina that will make the drug. The plant in Research Triangle Park has already received hefty investment from Lilly, and the new tranche will take the tally to $1.7 billion since 2020.
PharmaVoice
JANUARY 24, 2023
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra.
Pharma Pathway
JANUARY 24, 2023
Indoco Remedies Ltd.-Walk-In Interviews for Production/ Packing On 28th Jan’ 2023 Job Description Walk-In Interviews for Production/ Packing @ Indoco Remedies Ltd. Company Name: Indoco Remedies Ltd Department: Production/ Packing Qualification: B.Pharma Experience : 02 to 10 years Position: Sr. Officer/ Sr. Executive Job Location: Baddi Date: 28th Jan’ 2023 Time: 08:30 AM to 12:00 PM Venue: Indoco Remedies Limited Unit-III, Katha, Baddi (H.P.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
MedCity News
JANUARY 24, 2023
Medtech companies should have a team of FDA advisors at the ready to develop and implement pre- and post-market strategies, prevent and resolve pre- or post-market issues and guide lifecycle management
Pharma Pathway
JANUARY 24, 2023
Chemveda Life Sciences Pvt. Ltd- Walk-In Interviews for Discovery Chemistry Solutions On 27th Jan’ 2023 Job Description Dear Candidate, We are conducting Walk-In Interviews for multiple positions in Discovery Chemistry Solutions department (CRO) @ Chemveda Life Sciences Pvt. Ltd Department: Discovery Chemistry Solutions Designation: Research Associate/ Sr.
MedCity News
JANUARY 24, 2023
Clinical trial setbacks and financial challenges have led Finch Therapeutics to stop a Phase 3 study for its lead microbiome program, a potential treatment for recurrent C. diff infection. As Finch seeks buyers for its remaining assets, the biotech is laying off most of its staff in a corporate restructuring.
Pharma Pathway
JANUARY 24, 2023
Hetero Labs Limited-Walk-In Interviews for AR&D/ FR&D/ Analytical DQA On 28th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Copyright Clearance Center
JANUARY 24, 2023
The post CCC’s Award-Winning Customer Service Team Propels CX Program appeared first on Copyright Clearance Center.
Pharma Pathway
JANUARY 24, 2023
Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.
pharmaphorum
JANUARY 24, 2023
Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee. The RxPass service – open to Prime members – provides access to a range of more than 50 generics that are widely used to treat more than 80 common conditions, such as high blood pressure, anxiety, menopause and acid reflux, said Amazon in a blog post published today.
Pharma Pathway
JANUARY 24, 2023
Vital Pharma -Walk-In Drive for freshers & Experienced in Account/ Receptionist On 27th & 28th Jan’ 2023 Job Description Department: Receptionist Cum Office Assistant – Female Qualification: : Any Degree Experience: 0 years Skills: Receiving calls /Making calls/Maintaining data of the office/Inward out ward registers/Courier Management Duties: 1.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
232 
Let's personalize your content